Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions

Completed

• Conditions: Rhabdomyolysis; Myoglobinuria; Hemoglobinuria

• Registration Number: NCT00592657
• Lead Sponsor: Akron Children's Hospital

Brief Summary

Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Study First Submitted: 2008-01-01
• Study First Submitted QC: 2008-01-11
• Study First Posted: 2008-01-14
• Primary Completion: 2008-04
• Study Completion: 2008-04
• Status Verified: 2008-07
• Last Update Submitted: 2008-07-25
• Last Update Posted: 2008-07-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

• admitted to CHMCA between 1/1/1997 to 12/31/2007 with a qualifying ICD-9 diagnosis code for rhabdomyolysis, myoglobinuria, and hemoglobinuria (728.88, 791.2, 791.3)or other ICD-9 codes identified during the study
• between the ages of 0-21 years at diagnosis

Exclusion Criteria

• rhabdomyolysis or serum CK concentrations not actually documented
• patient admitted to the burn center
• patient > 21 years of age

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The presence of rhabdomyolysis based on serum CK concentrations in patients admitted with history of Jimsonweed ingestion.	From admission until discharge

Secondary Outcome Measures

Name	Time	Method
Renal function, liver function, vital signs, physical exam	From admission until discharge

Trial Locations

Locations (1)

Children's Hospital Medical Center of Akron; 🇺🇸 Akron, Ohio, United States